Technology
  • Home
  • About
    • Overview
    • Management
    • Board of Directors
    • Advisors & Consultants
  • Technology
    • Overview
    • Commercial Applications
    • Videos
    • Research
    • Patent Portfolio
    • Consumer Products
  • Licensing Opportunities
  • Investors
    • Overview
    • News & Events
    • Presentations
    • Company Info
    • Financial Info
    • Stock Data
    • SEC Filings
    • SEDAR
    • Legend Removal
    • Governance
  • Education
    • Background
    • Resources
    • General FAQs
  • Events
  • Contact

Press Releases

Investors

Investors

  • Overview
  • News & Events
    • Overview
    • Press Releases
    • IR Calendar
    • Email Alerts
  • Presentations
  • Company Info
    • Overview
    • Management Team
    • Contacts
    • 2020 Annual General Meeting
    • FAQ
  • Financial Info
    • Overview
    • Financial Results
    • Income Statement
    • Balance Sheet
    • Cash Flow
  • Stock Data
    • CSE: LXX
    • Nasdaq: LEXX
  • SEC Filings
    • Overview
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • SEDAR
  • Legend Removal
  • Governance
    • Board of Directors
    • Governance Documents
  • News & Events

  • Overview
  • Press Releases
  • IR Calendar
  • Email Alerts
Jun 22, 2017 8:00am EDT

Lexaria Files New Patent Application

May 30, 2017 7:50am EDT

Lexaria's Ambarii Corporation Announces LOI With Naturally Splendid to Distribute CBD Melts in Japan and South Korea

May 19, 2017 8:00am EDT

Lexaria raises US$1M from Warrant Exercise

May 10, 2017 8:00am EDT

Lexaria Announces Research on Nonsteroidal Anti-Inflammatory Drugs

May 04, 2017 8:00am EDT

Lexaria Announces R&D on Nicotine

May 02, 2017 8:05am EDT

Lexaria Announces Million Dollar Research and Development Program

Apr 18, 2017 8:05am EDT

Lexaria Welcomes Canada's Proposed Cannabis Legislation

Apr 10, 2017 8:00am EDT

Lexaria and Neutrisci Enter Cannabinoid Joint Venture

Mar 22, 2017 8:05am EDT

Lexaria Introduces TurboCBD(TM) Brand of High Absorption Full Spectrum Hemp Oil Capsules

Mar 14, 2017 8:05am EDT

Design Phase Underway for Studies to be Conducted by National Research Council and Lexaria

  • Previous
  • 1…
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • Next
RSS
  • Email Alerts
  • Tear Sheet
  • Contacts
  • RSS News Feed
medical cannabinoid research Lexaria Bioscience Corp. | Medical Cannabinoid Research | Home Logo

Lexaria Bioscience Corp. (CSE:LXX; NASDAQ:LEXX) has developed and out-licenses its disruptive and cost-effective DehydraTECH™ technology that promotes healthier administration methods, lower overall dosing and higher effectiveness of ingestible drugs and other beneficial molecules.

  • Home
  • About
  • Technology
  • Licensing Opportunities
  • Investors
  • News
  • Blog
  • Education
  • Events
  • Contact

250.765.6424
info@lexariabioscience.com

Lexaria Bioscience Corp.
#100-740 McCurdy Road
Kelowna, BC, V1X2P7

Privacy Policy

General Disclaimer:
No statement in this web site has been evaluated by the Food and Drug Administration (FDA). Furthermore, none of the statements in this web site should be construed as dispensing medical advice or making claims regarding the cure of diseases…

Read More

Copyright © 2021 All rights reserved. Web Design, Kelowna Photographers, SEO by Hiilite